• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 57,066.05
    -144.40 (--0.25%)
  • Authum Invest
    2,250.00 985.00(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 591.50(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 925.35(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Roopa Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Sree Rayalseema
  • BSE Code : 5239.0
  • ISIN : INE443C01010
58.97 1 (1.36%)
  • As on 25 Jul 2025 (EOD)
  • Today’s Low

    57.01
  • Today’s High

    59.00
  • Open

    59.00
  • Perv Close

    58.18
  • 52W Low

    47.26
  • 52W High

    114.90

Key Indicators

  • P/E(TTM)

    22.77

  • Mar.Cap (₹Cr.)

    46.38

  • Div & Yield %

    0.00

  • Book Value(₹)

    22.24

  • Debt-Equity Ratio

    1.36

  • AGM Date

    24-Jul-2025

  • EPS

    2.59

  • P/E Ratio

    22.77

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    46.38

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.87

  • BV (₹)

    22.20

  • Sales( ₹ in Cr.)

    120.69

  • NP (in Cr.)

    2.03

  • NP Var(%)

    41.0

  • Div%

    0.0

  • CPS (₹)

    3.70

  • EPS (₹)

    2.60

  • Traded Value (₹ in Lakhs)

    46.38

  • 52 Week High

    114.90

  • 52 Week Low

    47.26

  • Price BSE

    59.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    46.38

  • P/C Ratio

    16.10

  • P/E Ratio

    22.80

  • Price Vs.BV

    2.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 70.43 76.17 51.21 28.61 27.65 30.15
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 70.43 76.17 51.21 28.61 27.65 30.15
Other Income 1.13 0.65 0.06 0.08 1.09 0.28
Stock Adjustments 9.75 3.64 -6.68 4.88 2.20 2.43
Total Income 81.31 80.46 44.59 33.57 30.94 32.86
EXPENDITURE :            
Raw Materials 64.37 65.12 33.17 22.23 19.79 25.14
Power and Fuel Cost 2.87 2.71 1.90 2.14 2.64 1.84
Employee Cost 3.47 3.24 2.21 3.77 2.36 0.93
Other Manufacturing Expenses 2.47 2.48 1.97 1.20 1.29 1.04
Selling and Administration Expenses 1.91 1.71 1.30 1.26 1.75 1.08
Miscellaneous Expenses 0.65 0.65 0.54 0.16 0.18 0.04
Employee Benefit Expenses 3.47 3.24 2.21 3.77 2.36 0.93
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 75.73 75.92 41.08 30.77 28.01 30.07
Operating Profit 5.57 4.54 3.50 2.80 2.92 2.78
Interest 2.52 1.84 1.21 1.06 1.36 1.42
Gross Profit 3.05 2.70 2.29 1.74 1.56 1.36
Depreciation 0.87 0.89 0.93 0.81 0.76 0.57
Profit Before Tax 2.18 1.81 1.36 0.93 0.80 0.79
Current Tax 0.66 0.44 0.40 0.22 0.10 0.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.01 0.01 -0.05 0.00 0.33 0.04
Reported Net Profit 1.52 1.35 1.02 0.72 0.37 0.60
Extraordinary Items 0.08 0.00 0.00 0.00 0.00 0.01
Adjusted Net Profit 1.44 1.35 1.02 0.72 0.37 0.59
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 5.51 4.16 2.91 2.20 2.06 1.45
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 7.03 5.51 3.93 2.91 2.43 2.06
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.93 1.72 1.29 0.91 0.47 0.77
Earnings Per Share(Adj)-Unit Curr 1.93 1.72 1.29 0.91 0.47 0.77
Book Value 19.67 17.73 16.00 14.70 13.73 13.25
Book Value(Adj)-Unit Curr 19.67 17.73 16.00 14.70 13.73 13.25

Shareholding Pattern

  • Promoter Group

    48.03%

  • Public Share Holding

    51.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,913,617 37.04 2,913,617 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 864,047 10.99 864,047 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,777,664 48.03 3,777,664 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 250 0.00 250 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 20,000 0.25 0 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,250 0.26 250 2
2] Non Institution
Bodies Corporate 230,574 2.93 71,774 42
Clearing Members 900 0.01 900 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 615,054 7.82 69,454 220
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,405,151 17.86 1,340,751 10
Individuals holding nominal share capital up to Rs. 1 lakh 1,815,927 23.09 1,214,742 3,722
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,067,606 51.71 2,697,621 3,995
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,865,520 100.00 6,475,535 4,002

Company Background

Roopa Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Roopa Industries Ltd
  • BSE Code : 5239.0
  • ISIN : INE443C01010
  • Incorporation Year

    1985

  • Registered Office

    17/745 Alur Road
    Kurnool District, ADONI,
    Andhra Pradesh-518301

  • Telephone

  • FAX

    91-40-23310379

  • Chairman

    T G Raghavendra

  • Managing Director

    T G Raghavendra

  • Company Secretary

    I V Lakshmi

  • Auditor

    S T Mohite & Co/Yelamanchi & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

Roopa Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Roopa Industries 58.97 71.55 70.43 22.77 12.51
Abbott India 34,635.25 6,684.73 6,409.15 52.03 44.95
Astrazeneca Phar 9,021.20 1,756.92 1,716.29 194.84 32.94
P & G Health Ltd 5,829.95 1,166.89 1,151.26 38.53 39.76
Glaxosmi. Pharma 3,159.95 3,866.05 3,723.49 58.25 58.72
Cipla 1,487.25 20,029.57 19,044.85 23.29 21.40
Amrutanjan Healt 700.40 437.58 421.23 39.84 20.84
Fermenta Biotec. 383.00 442.21 430.53 16.67 17.61
Guj. Themis Bio. 363.15 174.19 169.82 81.06 44.82
Bliss GVS Pharma 152.90 703.42 667.20 23.38 9.16
Ambalal Sarabhai 34.63 19.33 4.04 32.06 2.10